TAMSULOSINE axapharm caps ret 0.4 mg 30 pce

7680581730058 CH-58173 G04CA02 05.99.0.
TAMSULOSINE axapharm caps ret 0.4 mg 30 pce
TAMSULOSINE axapharm caps ret 0.4 mg 30 pce
TAMSULOSINE axapharm caps ret 0.4 mg 30 pce
1 / 3
google

Details

Product number
5817301
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 7.3 µg, triethylis citras, talcum, Kapselhülle: E 172 (rubrum), E 171, E 172 (flavum), E 172 (nigrum), gelatina, E 132, pro capsula.

Articles (1)

Tamsulosin axapharm, Retardkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/09/2024
Patient information leaflet
Français
19/09/2024
Patient information leaflet
Italien
19/09/2024
Professional SmPC
Allemand
19/09/2024
Professional SmPC
Français
19/09/2024
Professional SmPC
Italien
19/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
0.4 MG Substance WIZUS
(N/A)
0.367 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
7.3 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 27.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2008

Authorization holder

axapharm ag

6340 Baar

Authorization information

Swissmedic authorization number
58173
Drug name
Tamsulosin axapharm, Retardkapseln
Galenic form
RETK
ATC Code
G04CA02
Authorization status
Z
Dispensation category
B
First authorization
01/02/2008
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
benigne Prostatahyperplasie

Packaging details

Description (FR)
TAMSULOSINE axapharm caps ret 0.4 mg 30 pce
Description (DE)
TAMSULOSIN axapharm Ret Kaps 0.4 mg 30 Stk
Market launch
01/02/2008
Narcotic (BTM)
No

Original drug

Omix Ocas 0.4 mg, Retardtabletten
CHF 16.40
View original

Other packaging sizes

TAMSULOSINE axapharm caps ret 0.4 mg 10 pce
10 KAP
View
TAMSULOSINE axapharm caps ret 0.4 mg 100 pce
100 KAP
View